Relipid+ Balm
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Relipid+ Balm, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults [NA]